End Of Week ... medical device industry recap |
|
 |
"Women in engineering face unique barriers that block their entry and progression in the engineering field including discrimination, a lack of role models, and a company culture that doesn’t accommodate other life commitments and events. Joanne Lucas, Culture and Inclusion Lead at WMFTS shares her views.
|
|
|
|
In the United States alone, almost 40 million people with diabetes face severe health risks due to accompanying chronic conditions like heart disease, stroke, and kidney failure. There is an APP that guides diabetics through easy-to-follow pathways that contribute to increased compliance with their care team’s plan, and most importantly, improved outcomes.
|
|
|
|
|
d'Artagnan Osborne writes, "Technology has come a long way to help improve the patient payment process." He describes how adopting new technology can benefit a healthcare practice and the patient! Read on to learn more.
|
|
|
|
Mr. Long writes, "The Hospital at Home model of healthcare gives patients more freedom of choice and autonomy over their own health and treatment decisions." Read his expert views.
|
|
|
|
June 27, 2022
Data from FAST-01, the first-ever human clinical trial of Flash, was used to support the approval of the FAST-02 study and will be reported later this year reports Varian.
June 27, 2022
Centerline Biomedical notes their flagship product, IOPS® (Intra-Operative Positioning System) was developed in Cleveland Clinic's Heart and Vascular Institute and utilizes patented algorithms to generate a patient-specific vascular map combined with electromagnetic tracking and smart sensor-equipped surgical devices to provide real-time, 3-D color visualization and navigation of the human vascular system.
June 27, 2022
Lidia Fonseca, Executive Vice President, Chief Digital and Technology Officer at Pfizer, has been appointed to the Medtronic Board as an independent director, effective June 27, 2022.
June 27, 2022
"This technology takes us to the next era of spine surgery," says Kevin Yao, MD, chief of neurosurgery at Englewood Health. "It facilitates more precise and more minimally invasive spine surgery, which will translate into shorter patient recoveries and better outcomes."
June 27, 2022
The patient had Systemic Lupus Erythematosus, a chronic autoimmune illness that can cause inflammation in the heart and other organs. The condition can influence heart ailment which can be observed in over half of lupus patients. The doctors chose to proceed with a robotic MVR as robotic surgeries have proven to be one of the most effective methods and is beneficial for the patient.
|
|
|
|
June 27, 2022
DeBogy Molecular notes the breakthrough technology found to safely reduce dangerous bacterial biofilm on Medical Implants by 99.9%, without the use of antibiotics or toxic chemicals.
|
|
|
|
June 28, 2022
Hominis Surgical System is the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide high dexterity and unprecedented articulation.
June 28, 2022
Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo drug-coated balloon in de-novo coronary artery disease lesions notes Advanced NanoTherapies.
June 28, 2022
VasQ External Support, a Laminate Medical Technologies device is implanted around the connection between the vein and artery during the creation of an arteriovenous fistula (AVF) for hemodialysis patients with the intent to provide structural reinforcement and promote a more stable flow profile.
June 28, 2022
Overcoming the Covid Darkness: How Two Doctors Successfully Treated 7000 Patients is available in various formats on Amazon.
June 28, 2022
The Renuvion Dermal handpiece for specific dermatological procedures is for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II or III.
|
|
|
|
June 28, 2022
"The new and used first-generation DreamStation devices passed volatile organic compound and respirable particulate emission testing." This is very encouraging said Frans van Houten, CEO of Royal Philips
|
|
|
June 29, 2022
NeuraLace Medical notes the new CPT codes will become effective on January 1, 2023, at which time providers can report the code(s) when performing the Axon Therapy procedure on patients across the United States.
|
|
June 30, 2022
Due to the expanded available patient population, HeartBeam expects to file a 510K with the full data set for clinical validation no later than August 15, 2022 and does not affect the timeline for 510K submission of the Telehealth product.
June 30, 2022
This trial will evaluate the safety and efficacy of the NeuroVasc ENVI™-SR, a stent-retriever intended for the treatment of acute ischemic stroke to reduce disability by removing blood clots in patients with stroke due to large vessel occlusion.
|
|
|
|
June 30, 2022
Sunflower Rx™ uses specific wavelengths of near-infrared light to bypass the skull and be directly absorbed by the brain notes JustLight.
|
|
|
|
June 30, 2022
Speaking on the news, Dr Ross O’Neill, Founding CEO of Neuromod said, “We’re delighted to announce the publication of positive results from the TENT-A2 clinical trial which show greater improvement in tinnitus symptoms from treatment with Lenire. Tinnitus remains one of the largest unmet clinical needs globally and I’m proud that Neuromod is at the forefront of developing bimodal neuromodulation technology to treat chronic tinnitus.
|
|
|
|
June 30, 2022
The LEGION CONCELOC Cementless Total Knee System addresses the critical elements of the cementless total knee through its unique design.
|
|
|
|
June 30, 2022
“I am thrilled to welcome Stanley Lu to our Board of Directors where he will join us in our common quest to treat and transform the lives of millions of patients each year by means of the ZAP-X surgical robot,” said Dr. John R. Adler, MD, Stanford Professor of Neurosurgery and founder & Chief Executive Officer of ZAP Surgical Systems.
|
|
|
June 30, 2022
The benefits of truly mobile compact devices cannot be underscored, and now by engineering the success of our head CT systems into an open-bore system, we are able to drive a new generation of Xoran's point-of-care (POC) imaging devices," said Misha Rakic, Xoran CEO.
July 1, 2022
This rebranding as ENDOQUEST Robotics reinforces their commitment to being the leader in innovation in flexible robotic technology for a wide range of needs in endoscopic surgeries in the years ahead.
|
|
|
Are you reading this email through Social Media? We invite you to click on the image to SUBSCRIBE. It's complimentary!
|
|
|
|
We Invite You to SUBSCRIBE to our Sister Publication!
|
|
|
|
PTM Healthcare Marketing, Inc., Public Relations & Marketing
|
|
Talk to Us on Social Media ------------ > |
|
|
|
|
|
|
|
